martes, 4 de octubre de 2022

Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease - Journal of Infection and Chemotherapy

Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease - Journal of Infection and Chemotherapy

No hay comentarios:

Publicar un comentario